BioSpace News Archive

Dicerna Pharmaceuticals, headquartered in Cambridge, Massachusetts, announced it has submitted a Clinical Trial Authorization (CTA) application to the Swedish Medical Products Agency (MPA).

The beginning of July is when many companies increase the price on prescription medications in the U.S. This year’s price increases are higher than the same period last year.

Amarin Corporation, based in Bedminster, New Jersey and Dublin, Ireland, provided a mid-year update, noting that it is planning to dramatically expand its sales force for Vascepa.

Laser Clinics Australia, Australia’s largest retail aesthetics clinics chain and Kleresca®, an innovative Danish/Irish med-tech company focusing on fluorescent light energy in skin treatments have formed a strategic partnership whereby the Kleresca® FLE technology will be made available to the LCA customer base in Australia.

These results include reduction in monthly average migraine days; reduction in migraine related symptoms; and improvements in depression status; work productivity and activity impairment.

Nanologica enters into an agreement with Chinese Yunbo Technology (Beijing) Co. for the delivery of preparative chromatography media to a value of approximately MUSD 14.

The last, large, isolated, healthy chlamydia-free population of koalas in Australia may have been identified on Kangaroo Island, said Morris Animal Foundation-funded researchers at the University of Adelaide.

Leading Pancreatic Cancer Advocacy Organization’s Scientific and Clinical Board Guides Planning of Research Initiatives and Services for Patients, Caregivers and Healthcare Professionals

The National Institute of Health awarded contract aims to help find ways to treat rare diseases

Compugen Ltd., a clinical-stage cancer immunotherapy company and leader in predictive target discovery, announced the appointment of Mr. Eran Perry to its board of directors, effective July 1, 2019.